Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Powers

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
ACS Infectious Diseases|November 17, 2017
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-LactamaseAlexandra A Bouza, Hollister C Swanson, Kali A Smolen, et al.
ACS Infectious Diseases|June 6, 2020
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against <i>Acinetobacter baumannii</i> CephalosporinaseEmilia Caselli, Francesco Fini, Maria Luisa Introvigne, et al.
Journal of Molecular Biology|May 10, 2024
Structural and Dynamic Features of Acinetobacter baumannii OXA-66 β-Lactamase Explain Its Stability and Evolution of Novel VariantsZachary L Klamer, Cynthia M June, Zdzislaw Wawrzak, et al.
Biochemistry|February 25, 2015
Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumanniiJoshua M Mitchell, Jozlyn R Clasman, Cynthia M June, et al.
Mbio|May 16, 2025
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the <i>Acinetobacter</i>-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant <i>Acinetobacter baumannii</i> (CR<i>Ab</i>)Rachel A Powers, Bradley J Wallar, Hannah R Jarvis, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.
Diagnostic Microbiology and Infectious Disease|November 28, 2020
A comprehensive and contemporary "snapshot" of β-lactamases in carbapenem resistant Acinetobacter baumanniiAndrea M Hujer, Kristine M Hujer, David A Leonard, et al.
Journal of Medicinal Chemistry|June 26, 2023
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits <i>Acinetobacter</i>-Derived Cephalosporinase Variants with an Expanded-Substrate SpectrumRachel A Powers, Cynthia M June, Micah C Fernando, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
ACS Infectious Diseases|November 17, 2017
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-LactamaseAlexandra A Bouza, Hollister C Swanson, Kali A Smolen, et al.
ACS Infectious Diseases|June 6, 2020
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against <i>Acinetobacter baumannii</i> CephalosporinaseEmilia Caselli, Francesco Fini, Maria Luisa Introvigne, et al.
Journal of Molecular Biology|May 10, 2024
Structural and Dynamic Features of Acinetobacter baumannii OXA-66 β-Lactamase Explain Its Stability and Evolution of Novel VariantsZachary L Klamer, Cynthia M June, Zdzislaw Wawrzak, et al.
Biochemistry|February 25, 2015
Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumanniiJoshua M Mitchell, Jozlyn R Clasman, Cynthia M June, et al.
Mbio|May 16, 2025
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the <i>Acinetobacter</i>-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant <i>Acinetobacter baumannii</i> (CR<i>Ab</i>)Rachel A Powers, Bradley J Wallar, Hannah R Jarvis, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.
Diagnostic Microbiology and Infectious Disease|November 28, 2020
A comprehensive and contemporary "snapshot" of β-lactamases in carbapenem resistant Acinetobacter baumanniiAndrea M Hujer, Kristine M Hujer, David A Leonard, et al.
Journal of Medicinal Chemistry|June 26, 2023
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits <i>Acinetobacter</i>-Derived Cephalosporinase Variants with an Expanded-Substrate SpectrumRachel A Powers, Cynthia M June, Micah C Fernando, et al.
Pageof 3